An Investigator And Subject-Blind Phase 1 Study To Characterize the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Subjects.

Trial Profile

An Investigator And Subject-Blind Phase 1 Study To Characterize the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Jul 2011

At a glance

  • Drugs PF 4995274 (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 20 Jul 2011 Results presented at the 2011 International Conference on Alzheimer's Disease.
    • 19 Jan 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
    • 19 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top